Michael Tsai, Chairman of Darwin Precisions Corporation, stated that the company is no longer just a display manufacturer but now provides comprehensive solutions that truly address customer needs. With new applications gradually coming to fruition, Darwin is actively expanding into multiple fields, embarking on a new phase of growth.

Tsai noted that over the past two years, Darwin has obtained certifications from automotive clients, with results to be progressively showcased this year and next. Additionally, the company has entered the biomedical market with beauty products and organ-on-a-chip devices suitable for animal testing, all of which have already begun shipping and are expected to ramp up gradually.

In recent years, Darwin has been vigorously optimizing its core business while simultaneously pushing forward diversified development strategies. Tsai emphasized that Darwin’s multi-field expansion leverages its microstructure technology to penetrate biotech applications in medical aesthetics and healthcare. At the same time, through the integration of microstructure technology and systems, the company is investing in the development of biomedical and organ-on-a-chip detection components, instruments, and integrated systems, focusing on related technologies and product R&D.

Resource: 達運布局多元場域